Cargando…

MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma

The prognosis of patients with advanced renal cell carcinoma (RCC) has improved with newer therapies, including molecular-targeted therapies and immuno-oncology agents. Despite these therapeutic advances, many patients with metastatic disease remain uncured. Inhibition of glycogen synthase kinase-3β...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murata, Masaki, Bilim, Vladimir, Shirono, Yuko, Kazama, Akira, Hiruma, Kaede, Tasaki, Masayuki, Tomita, Yoshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529713/ https://www.ncbi.nlm.nih.gov/pubmed/37754254 http://dx.doi.org/10.3390/cimb45090470

Ejemplares similares

Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma
por: Kazama, Akira, et al.
Publicado: (2022)

Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells
por: Shirono, Yuko, et al.
Publicado: (2023)

Advanced Bladder Cancer: Changing the Treatment Landscape
por: Bilim, Vladimir, et al.
Publicado: (2022)

Development of patient-derived tumor organoids and a drug testing model for renal cell carcinoma
por: Kazama, Akira, et al.
Publicado: (2021)

Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment
por: Kuroki, Hiroo, et al.
Publicado: (2021)

Clinically relevant GSK-3β inhibitor 9-ING-41 is active as a single agent and in combination with other antitumor therapies in human renal cancer
por: Anraku, Tsutomu, et al.
Publicado: (2020)

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
por: Kuroki, Hiroo, et al.
Publicado: (2019)

GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition
por: Ito, Hiromi, et al.
Publicado: (2016)

Ulcerative interstitial cystitis in an adolescent successfully treated with complete transurethral ulcer resection: A case report
por: Yuki, Eri, et al.
Publicado: (2018)

MicroRNAs in renal fibrosis
por: Chung, Arthur C.-K., et al.
Publicado: (2015)

Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
por: McCubrey, James A., et al.
Publicado: (2016)

The Role of microRNAs in Cholangiocarcinoma
por: Shi, Tingting, et al.
Publicado: (2021)

A Case of Myxoid Adrenocortical Neoplasm: Computed Tomography and Magnetic Resonance Imaging Characteristics
por: Fukuhara, Hiroki, et al.
Publicado: (2013)

Long-term CMV monitoring and chronic rejection in renal transplant recipients
por: Ishikawa, Shoko, et al.
Publicado: (2023)

The role of microRNAs in bladder cancer
por: Enokida, Hideki, et al.
Publicado: (2016)

The VHL-dependent regulation of microRNAs in renal cancer
por: Neal, Calida S, et al.
Publicado: (2010)

MicroRNAs as non-invasive biomarkers of renal disease
por: Connor, Katie L, et al.
Publicado: (2019)

Integrated Profiling of MicroRNAs and mRNAs: MicroRNAs Located on Xq27.3 Associate with Clear Cell Renal Cell Carcinoma
por: Zhou, Liang, et al.
Publicado: (2010)

Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients
por: Sugimachi, Keishi, et al.
Publicado: (2015)

MicroRNAs in Human Malignant Gliomas
por: Mizoguchi, Masahiro, et al.
Publicado: (2012)

Grazing Affects Exosomal Circulating MicroRNAs in Cattle
por: Muroya, Susumu, et al.
Publicado: (2015)

Novel MicroRNA Reporter Uncovers Repression of Let-7 by GSK-3β
por: Guo, Rong, et al.
Publicado: (2013)

MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma
por: Tian, Tian, et al.
Publicado: (2016)

Multiple endocrine disorders manifested as gynecomastia in a patient with renal pelvis cancer
por: Bilim, Vladimir, et al.
Publicado: (2022)

The Role of microRNAs in the Infection by T. gondii in Humans
por: de Faria Junior, Geraldo Magela, et al.
Publicado: (2021)

MicroRNAs in Neurotoxicity
por: Kaur, Prameet, et al.
Publicado: (2012)

MicroRNAs and senescence
por: Martinez, Ivan, et al.
Publicado: (2011)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

MicroRNAs in metabolism
por: Vienberg, S., et al.
Publicado: (2016)

MicroRNAs in Development
por: Maatouk, Danielle, et al.
Publicado: (2006)

MicroRNAs and Osteoarthritis
por: Malemud, Charles J.
Publicado: (2018)

MicroRNAs and Presbycusis
por: Hu, Weiming, et al.
Publicado: (2018)

MicroRNAs and Metastasis
por: Solé, Carla, et al.
Publicado: (2019)

MicroRNAs in Dystrophinopathy
por: Lee, Ahyoung, et al.
Publicado: (2022)

MicroRNAs and Nonalcoholic Steatohepatitis: A Review
por: Morishita, Asahiro, et al.
Publicado: (2023)

Data on microRNAs and microRNA-targeted mRNAs in Xenopus ectoderm
por: Shah, Vrutant V., et al.
Publicado: (2016)

Clinical implications of microRNAs in human glioblastoma
por: Mizoguchi, Masahiro, et al.
Publicado: (2013)

Modulation of microRNA Activity by Semi-microRNAs
por: Plante, Isabelle, et al.
Publicado: (2012)

Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients
por: Itoi, T, et al.
Publicado: (2004)

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review
por: Morishita, Asahiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7u6de2hrcq7q5oohbtm4lotnu2